Search
We investigated the suggestion that otitis-prone children have an impaired antibody response in the context of pneumococcal vaccination.
Reviewed in this article these studies have identified positive association at 21 genes with association at five of these replicated in independent populations.
Vaccines including conserved antigens from Streptococcus pneumoniae & nontypeable Haemophilus influenzae have the potential to reduce of otitis media.
A The Kids Research Institute Australia ear health researcher has received a prestigious national fellowship to support her search for new therapies to improve the lives of kids who suffer repeat middle ear infections.
Two The Kids Research Institute Australia researchers have been named as finalists in the 2020 Western Australian Premier’s Science Awards.
Congratulations goes to Celestine Aho, the inaugural winner of the $30,000 Deborah Lehmann Research Award.
Acknowledging the enormous efforts in ear health programs across WA, we invite stakeholders to assist us in establishing research priorities.
The Advisory Council on the Prevention of Deaths of Children and Young People today officially released this report.
Otitis media (OM) is a common childhood disease characterised by middle ear inflammation following infection
In Australia the 7-valent pneumococcal conjugate vaccine (PCV7) is administered at 2, 4 and 6 months of age, with no booster dose.